Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CareRx Corp T.CRRX

Alternate Symbol(s):  CHHHF

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.


TSX:CRRX - Post by User

Bullboard Posts
Post by TheRock07on Aug 23, 2016 6:56am
247 Views
Post# 25166746

McKesson paid 1.3 times sales for Rexall Drugs

McKesson paid 1.3 times sales for Rexall DrugsMcKesson just paid 1.3 times annual sales for Rexall Drugs.
Rexall's ebitda margins were about 10% which is a bit below that of Pharmacare.

Based on this metric, CHH is currently worth about $225  million.

ITG has been accumulating recently, and with yesterday's cross now owns 2.3 million shares.

The IDA/Guradian ( McKesson) 10 year deal with CHH clearly defines an emerging pharmaceutical/ healthcare group that is well prepared for the expanded healthcare role that pharmacies are now being prepared for.

This includes many functions formerly carried out by physicians.

Buy on any manipulated weakness such as we saw yesterday.


Bullboard Posts